Bank Pictet & Cie (Asia) LTD Vertex Pharmaceuticals Inc Transaction History

Bank Pictet & Cie (Asia) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $433,159 - $484,740	-2,388 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $22,498 - $26,532	120 Added 5.29%	2,388 $481,000
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $55,481 - $64,671	268 Added 13.4%	2,268 $487,000
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $414,020 - $552,180	2,000 New	2,000 $473,000

1,721

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.